论文信息 - IDH mutation status in prostate cancer - 字舞流文

IDH mutation status in prostate cancer

R. Bristow | T. Mak | R. Cairns | J. Thoms | O. Ahmed | A. F. Ghiam | A. Meng | A. D. Pra

[1] Arul M Chinnaiyan,et al. Metabolism unhinged: IDH mutations in cancer , 2011, Nature Medicine.

[2] K. Yen,et al. Cancer-associated IDH mutations: biomarker and therapeutic opportunities , 2010, Oncogene.

[3] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[4] N. Yoo,et al. Absence of IDH2 codon 172 mutation in common human cancers , 2009, International journal of cancer.

[5] N. Yoo,et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers , 2009, International journal of cancer.

[6] T. H. van der Kwast,et al. High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancer , 2009, The Prostate.

[7] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.

[8] Richard P. Hill,et al. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[9] R. Bristow,et al. Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. , 2007, Future oncology.